Electrode re-implantation helps some Parkinson's disease patients

May 12, 2008

A study of seven patients with Parkinson’s disease suggests that those who have poor results following implantation of electrodes to stimulate the brain may benefit from additional surgery to correct the electrode placement, according to a report in the May issue of Archives of Neurology.

Implanting electrodes that stimulate the subthalamic nucleus, a region deep in the brain potentially related to impulsivity, is effective in reducing medication doses and improving the symptoms of Parkinson’s disease, according to background information in the article. With this treatment, medication doses are often reduced by 50 percent to 65 percent, and scores on scales measuring motor function (generally impaired in Parkinson’s disease) typically improve by 40 percent to 70 percent. However, sometimes the surgery is less effective.

“The principal cause of these poor results arises from imprecision of electrode placement, leading to non-stimulation of the target as required,” the authors write. “Misplacement of the electrode by only a few millimeters may have occurred.”

Mathieu Anheim, M.D., of the University Hospital A. Michallon, Strasbourg, France, and colleagues studied seven consecutive patients age 49 to 70 with Parkinson’s disease who, despite electrode implantation, continued to experience severe symptoms. The patients were operated on again and the electrodes were re-implanted 12 to 23 months after the original surgery. Motor scores and medication doses were assessed one year after the second procedure.

All patients except for one displayed improvement after the second surgery. When they were not on medication, treatment improved the patient’s motor scores by 26.7 percent following the first operation and 59.4 percent following the second procedure. Their dose of levodopa, a medication treating Parkinson’s disease, decreased from 1,202 milligrams to 534 milligrams. The average distance between the electrodes and the target point of stimulation—a location in the subthalamic nucleus identified by evaluating electrode placement in patients whose surgery was successful—decreased from 5.4 to 2 millimeters. The shorter this distance, the greater the patient’s improvement in motor scores.

Source: JAMA and Archives Journals


print this article email this article download pdf blog this article bookmark this article     Stumble it Digg this share on Facebook retweet share on Reddit add to delicious
Rate this story - not rated yet


May 12, 2008 all stories

Comments: 0

not rated yet
  • Stumble this up

  • Digg this

  • share this

  • hide
  • Related Stories




  • hide
  • Relevant PhysicsForums posts

Other News

New cancer target for non-Hodgkin's lymphoma

Medicine & Health / Cancer

created 12 hours ago | popularity 5 / 5 (1) | comments 0

Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin's lymphoma, a type of cancer that affects lymphocytes, ...


Surface bacteria maintain skin's healthy balance

Medicine & Health / Research

created 13 hours ago | popularity 5 / 5 (4) | comments 0

On the skin's surface, bacteria are abundant, diverse and constant, but inflammation is undesirable. Research at the University of California, San Diego School of Medicine now shows that the normal bacteria living on the ...


Gene mismatch influences success of bone marrow transplants

Medicine & Health / Genetics

created 13 hours ago | popularity 4 / 5 (1) | comments 0

A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Ge ...


New understanding about mechanism for cell death after stroke leads to possible therapy

Medicine & Health / Research

created 13 hours ago | popularity not rated yet | comments 0

Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which ...


Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer

Medicine & Health / Cancer

created 13 hours ago | popularity not rated yet | comments 0

Agios Pharmaceuticals today announced that its scientists have established, for the first time, that the mutated IDH1 gene has a novel enzyme activity consistent with a cancer-causing gene, or oncogene. This breakthrough ...